The legislative landscape remains unsettled. Most bills are still in committee or early stages. The specific enforcement mechanisms and audit protocols state insurance departments will employ are not yet detailed in public filings. It is unclear whether these state-level rules will preempt or coordinate with federal guidance, including recent White House directives on AI oversight.
Insurers operating across multiple states now face a fragmented compliance burden. The core requirement emerging across jurisdictions is transparency: AI cannot be a black box in coverage decisions, and human clinical judgment must remain the final arbiter. Counsel should monitor state insurance department guidance as these laws take effect and track whether enforcement actions target specific denial patterns or algorithmic bias. The trend signals state legislatures view federal oversight as insufficient and are willing to constrain automation in coverage decisions to protect patients.